Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: A single-center experience of 381 cases

Hepato-Gastroenterology

Volumn 53, Issue 68, 2006, Pages 275-280

  Zhou, Jian ^a   Tang, Zhao You ^a   Wu, Zhi Quan ^a   Zhou, Xin Da ^a   Ma, Zeng Chen ^a   Tan, Chang Jun ^a   Shi, Ying Hong ^a   Yu, Yao ^a   Qiu, Shuang Jian ^a   Fan, Jia ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Portal vein tumor thrombosis; Prognostic factors; Surgery; Survival

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; CALCULATION; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORTAL VEIN THROMBOSIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TIME; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 33645563781     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Parkin DM, Bray F, Ferlay J, et al: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94:153-156.
2. Yamamoto J, Kosuge T, Takayama T, et al: Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996; 83:1219-1212.
3. Toyosaka A, Okamoto E, Mitsunobu M, et al: Pathologic and radiographic studies of intrahepatic metastasis in hepatocellular carcinoma; the role of efferent vessels. HPB Surg 1996; 10:97-103.
4. Tanaka T, Yamanaka N, Oriyama T, et al: Factors regulating tumor pressure in hepatocellular carcinoma and implications for tumor spread. Hepatology 1997; 26:283-287.
5. Cha C, Fong Y, Jarnagin WR, et al: Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 2003; 197:753-758.
6. Giannelli G, Pierri F, Trerotoli P, et al: Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases. Hepatol Res 2002; 24:50-59.
7. Yeh CN, Chen MF, Lee WC, et al: Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 2002; 81:195-202.
8. Ando E, Tanaka M, Yamashita F, et al: Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Cancer 2002; 95:588-595.
9. Ando E, Yamashita F, Tanaka M, et al: A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer 1997; 79:1890-1896.
10. Minoyama A, Yoshikawa M, Ebara M, et al: Study of repeated arterial infusion chemotherapy with a subcutaneously implanted reservoir for advanced hepatocellular carcinoma. J Gastroenterol 1995; 30:356-366.
11. Fukuda S, Okuda K, Imamura M, et al: Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: Report of 19 cases. Surgery 2002; 131:300-310.
12. Fan J, Wu ZQ, Zhou J, et al: Hepatocellular carcinoma associated with tumor thrombosis in the portal vein: the effects of different treatments. Hepatobiliary Pancreat Dis Int 2003; 2:513-519.
13. Bilimoria MM, Lauwers GY, Doherty DA, et al: Underlying liver disease but not tumor factors predict long-term survival after hepatic resection of hepatocellular carcinoma. Arch Surg 2001; 136:528-535.
14. Imamura H, Matsuyama Y, Tanaka E, et al: Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38:200-207.
15. Kumada T, Nakano S, Takeda I, et al: Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997; 25:87-92.
16. Uraki J, Yamakado K, Nakatsuka A, et al: Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors. Eur J Radiol 2004; 51:12-18.
17. Daly JM, Kemeny N, Sigurdson E, et al: Regional infusion for colorectal hepatic metastases: a randomized trial comparing the hepatic artery with the portal vein. Arch Surg 1987; 122:1273-1277.
18. Okuno K, Hirohata T, Nakamura K, et al: Hepatic arterial infusions of interleukin-2 (IL-2)-based immunochemotherapy in the treatment of unresectable liver metastases from colorectal cancer. Clin Ther 1993; 15:672-683.
19. Fong Y, Sun RL, Jarnagin W, et al: An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229:790-800.
20. Edmondson HA, Steiner PE: Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 1954; 7:462-503.
21. Tarao K, Rino Y, Ohkawa S, et al: Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer 1999; 86:589-595.
22. Chena WT, Chaua GY, Luia WY, et al: Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. EJSO 2004; 30:414-420.
23. Morimoto O, Nagano H, Sakon M, et al: Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas. J Hepatol 2003; 39:215-221.
24. Tsai TJ, Chau GY, Lui WY, et al: Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000; 127:603-608.
25. Llovet JM, Bustamante J, Castells A, et al: Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29:62-67.
26. Lee HS, Kim JS, Choi IJ, et al: The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. Cancer 1997; 79:2087-2094.
27. Chung JW, Park JH, Han JK, et al: Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. Am J Roentgenol 1995; 165:315-321.
28. Okada S, Okazaki N, Nose H, et al: Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology 1992; 16:112-117.
29. Ohkubo T, Yamamoto J, Sugawara Y, et al: Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg 2000; 191:657-660.
30. Konishi M, Ryu M, Kinoshita T, et al: Surgical treatment of hepatocellular carcinoma with direct removal of the tumor thrombus in the main portal vein. Hepatogastroenterology 2001; 48:1421-1424.
31. Nagasue N, Uchida M, Makino Y, et al: Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105:488-494.
32. Nagasue N, Ono T, Yamanoi A, et al: Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg 2001; 88:515-522.
33. Ikeda Y, Kajiyama K, Adachi E, et al: Early recurrence after surgery of hepatocellular carcinoma. Hepatogastroenterology 1995; 42:469-472.
34. Sakon M, Umeshita K, Nagano H, et al: Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves. Arch Surg 2000; 135:1456-1459.
35. Ko S, Nakajima Y, Kanehiro H, et al: Influence of associated viral hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. World J Surg 1996; 20:1082-1086.
36. Huang YH, Wu JC, Chau GY, et al: Detection of serum hepatitis B, C, and D viral nucleic acids and its implications in hepatocellular carcinoma patients. J Gastroenterol 1998; 33:512-516.
37. Shimada M, Hasegawa H, Gion T, et al: Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy. Hepatogastroenterology 1999; 46:2469-2475.
38. Tang ZY, Yu YQ, Zhou XD, et al: Progress and prospects in hepatocellular carcinoma surgery. Ann Chir 1998; 52:558-563.
39. Poon RT, Fan ST, Lo CM, et al: Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999; 229:216-222.
40. Arii S, Teramoto K, Kawamura T, et al: Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience. J Hepatobiliary Pancreat Surg 2001; 8:397-403.
41. Arii S, Monden K, Niwano M, et al: Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepatobiliary Pancreat Surg 1998; 5:86-92.
42. Matsuda M, Fujii H, Kono H, et al: Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. J Hepatobiliary Pancreat Surg 2001; 8:353-359.
43. Nagao T, Inoue S, Goto S, et al: Hepatic resection for hepatocellular carcinoma: clinical features and long-term prognosis. Ann Surg 1987; 205:33-40.
44. Schoniger-Hekele M, Muller C, Kutilek M, et al: Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut 2001; 48:103-109.
45. Zhou XD, Tang ZY, Yang BH, et al: Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 2001; 91:1479-1486.
46. Colleoni M, Vicario G, Manente P, et al: Activity and tolerability of courses of intra-arterial chemotherapy followed by chemoembolization in unresectable hepatocellular carcinoma. Tumori 1998; 84:673-676.
47. Sigurdson ER, Ridge JA, Kemeny N, et al: Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol 1987; 5:1836-1840.
48. Shirabe K, Takenaka K, Taketomi A, et al: Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 1996; 77:1050-1055.
49. Ikeda K, Saitoh S, Koida I, et al: A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18:47-53.
50. Uenishi T, Kubo S, Hirohashi K, et al: Relationship between response to previous interferon therapy and postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma. Hepatol Res 2002; 24:404-412.